My Companies
Notification
Account
Log Out
Login
Acquired Wellness Portfolio of Group Pharmaceuticals via slump sale for Rs23.7cr upfront plus up to Rs23cr linked to FY28 sales, capped at Rs46.7cr. Portfolio of wellness products focused on women's healthcare with FY26 revenue of Rs24.6cr. Completion by 1 Nov 2026.
Jagsonpal Completes Group Pharma Wellness Portfolio Acquisition For Rs 23.7 Crore
Jagsonpal Pharmaceuticals Acquires 85% Stake In Aequitas For ₹20.8 Crore